Coca-Cola tops earnings estimates, hikes full-year outlook as global demand rises

Coca-Cola tops earnings estimates, hikes full-year outlook as global demand rises


Coca-Cola beverages are offered for sale in Chicago on April 30, 2024.

Scott Olson | Getty Images

Coca-Cola on Tuesday raised its full-year outlook as global demand for its drinks rose in the second quarter.

For 2024, Coke now expects organic revenue growth of 9% to 10%, up from its prior forecast of 8% to 9%. The company also raised its outlook for comparable earnings growth to a range of 5% to 6% from a previous range of 4% to 5%.

Shares of the company rose about 1% in premarket trading.

Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

  • Earnings per share: 84 cents adjusted versus 81 cents expected
  • Revenue: $12.36 billion versus $11.76 billion expected

Coke reported second-quarter net income attributable to shareholders of $2.41 billion, or 56 cents per share, down from $2.55 billion, or 59 cents per share, a year earlier.

Excluding restructuring costs, charges related to the value of the Fairlife milk brand and other items, the beverage giant earned 84 cents per share.

Net sales rose 3% to $12.36 billion. Organic revenue, which strips out acquisitions, divestitures and foreign currency, climbed 15% in the quarter.

Coke’s unit case volume rose 2% for the quarter, helped by its international markets. The metric strips out the impact of pricing and foreign currency to reflect demand.

But in North America, volume fell 1% for the quarter. Coke said North American volume declined for its water, sports, coffee tea, trademark Coca-Cola and other soda brands, offsetting growth for its juice, dairy and plant-based beverages. Coke’s rival PepsiCo reported earlier this month that the U.S. consumer has weakened, hurting demand for its own drinks and snacks.

Coke’s sparkling soft drinks division, which includes its namesake soda, saw its global volume rise 3%, thanks to strong demand in the Asia Pacific and Latin America regions. Its juice, dairy and plant-based beverages business reported volume growth of 2%. And the water, sports, coffee and tea division saw flat volume, hurt by shrinking demand for bottled water and falling Costa coffee sales in the United Kingdom.

Coke’s overall prices were up 9% compared with the year-ago period, but about half of that came from hyperinflation in certain markets, like Argentina.

For the third quarter, Coke anticipates that foreign currency will again drag on its results. The company is forecasting a 4% currency headwind to its comparable net sales and an 8% currency headwind to its comparable earnings per share.

Don’t miss these insights from CNBC PRO



Source

Wendy’s CEO Kirk Tanner tapped to lead Hershey
Business

Wendy’s CEO Kirk Tanner tapped to lead Hershey

Kirk Tanner, then chief executive officer of North America beverages for PepsiCo Inc., speaks during the Bloomberg Power Players Summit in Miami, Florida, U.S., on Friday, Jan. 31, 2020.  Marco Bello | Bloomberg | Getty Images Wendy’s CEO Kirk Tanner has been named the new chief executive of The Hershey Company, effective August 18. Tanner […]

Read More
‘F1’ is Apple’s highest-grossing theatrical film ever
Business

‘F1’ is Apple’s highest-grossing theatrical film ever

Still from Apple’s “F1.” Apple Lights out and away we go. “F1: The Movie” hasn’t even reached the checkered flag of its theatrical run, but it’s already Apple’s best film release ever. The film, distributed by Warner Bros. Discovery, zoomed past $293 million at the global box office over the weekend. This outpaced Ridley Scott’s […]

Read More
Family offices ramp up deal-making in June with bets on biotech
Business

Family offices ramp up deal-making in June with bets on biotech

Key Points After a slow spring, investment firms of the ultra-rich made 60 direct investments in June, according to Fintrx. Family offices flocked to biotech and health-care firms such as Antheia, seeking to make an impact and returns at the same time. Antheia founder Christina Smolke told CNBC’s Inside Wealth family offices’ patient capital makes […]

Read More